Skip to main content
. 2021 Jun 7;12:3406. doi: 10.1038/s41467-021-23494-1

Fig. 7. LGALS3BP interacts with SARS-CoV-2 spike glycoprotein.

Fig. 7

a Magnetic bead-based affinity isolation of binding partners using His-tagged SARS-CoV-2 spike glycoprotein as a bait for proteins in SARS-CoV-2-positive patient plasma (n = 8). Volcano plot depicting significantly enriched constant chains of immunoglobulins. b Volcano plot depicting significantly enriched non-immunoglobulin proteins (n = 8). c Comparison of SARS-CoV-2 spike glycoprotein pulldown using plasma from COVID-19 ICU patients (n = 8) and non-COVID-19 patients (n = 3). Significance was determined by paired Student’s t tests for (a) and (b) and unpaired Student’s t tests for (c). d LGALS3BP levels across three patient cohorts as determined by DIA-MS or ELISA: control patients before undergoing elective cardiac surgery (n = 30), pre-pandemic sepsis ICU patients (n = 12) and COVID-19 ICU patients (n = 74). Kruskal–Wallis and Dunn’s multiple comparisons tests were used to determine statistical significance. e Volcano plot representing protein changes between baseline plasma samples from patients in ICU with either sepsis (n = 12) or COVID-19 (n = 12). Significance was determined through the Mann–Whitney U test with Benjamini-Hochberg’s FDR correction. f Plasma proteins correlating to LGALS3BP after age and sex corrections in COVID-19 ICU patients (n = 12) are highlighted by a Spearman correlation matrix across the proteomic dataset. Proteins with a Spearman correlation coefficient greater than 0.5 were used for gene ontology pathway enrichment analysis (Supplementary Fig. 10). All statistical analyses are two-tailed.